SFDA Reports 83% Surge in Clinical Research Submissions for Biotechnology Products in 2025
Riyadh: The Kingdom of Saudi Arabia recorded a landmark 83% growth in the number of clinical trial applications submitted to the Saudi Food and Drug Authority (SFDA) for advanced therapies and biotechnology products in 2025, compared to the previous y…